冠状病毒病（COVID-19）在伊朗爆发的一个方面：多发性硬化症患者高度焦虑。
One Aspect of Coronavirus disease (COVID-19) Outbreak in Iran: High Anxiety among MS Patients.
机构信息
Multiple Sclerosis Research Center; Neuroscience institute; Tehran University of Medical Sciences; Tehran; Iran.
出版信息
Mult Scler Relat Disord. 2020 Jun;41:102138. doi: 10.1016/j.msard.2020.102138. Epub 2020 Apr 20.
Abstract
• The incidence rate of COVID-19 is increasing in Iran on each successive day. • This increasing incidence causes anxiety in Iranian population. • This study revealed a significant level of anxiety among the MS patients.
摘要
• 伊朗 COVID-19 的发病率每天都在持续增加。
• 这种不断上升的发病率使伊朗民众感到焦虑。
• 本研究显示 MS 患者的焦虑程度显著。
相似文献
1
One Aspect of Coronavirus disease (COVID-19) Outbreak in Iran: High Anxiety among MS Patients.冠状病毒病（COVID-19）在伊朗爆发的一个方面：多发性硬化症患者高度焦虑。
Mult Scler Relat Disord. 2020 Jun;41:102138. doi: 10.1016/j.msard.2020.102138. Epub 2020 Apr 20.
2
Evaluation of the Level of Anxiety among Iranian Multiple Sclerosis Fellowships During the Outbreak of COVID-19.新冠疫情期间伊朗多发性硬化症患者群体焦虑水平评估
Arch Iran Med. 2020 Apr 1;23(4):283. doi: 10.34172/aim.2020.13.
3
Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (COVID-19) Pandemic.冠状病毒病（COVID-19）大流行期间帕金森病患者焦虑症的发病率
Mov Disord. 2020 Jul;35(7):1095-1096. doi: 10.1002/mds.28116. Epub 2020 May 21.
4
Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak.复发缓解型多发性硬化症患者在 2019 冠状病毒病疫情期间的心理状况。
Mult Scler Relat Disord. 2020 Oct;45:102407. doi: 10.1016/j.msard.2020.102407. Epub 2020 Jul 16.
5
Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic.一名多发性硬化症患者在大流行期间开始使用奥瑞珠单抗治疗，感染新冠病毒后预后良好。
Mult Scler Relat Disord. 2020 Aug;43:102222. doi: 10.1016/j.msard.2020.102222. Epub 2020 May 23.
6
Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problems.伊朗2019冠状病毒病（COVID-19）疫情：行动与问题
Infect Control Hosp Epidemiol. 2020 Jun;41(6):754-755. doi: 10.1017/ice.2020.86.
7
B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.B 细胞耗竭疗法可能会影响伊朗 COVID-19 疫情早期多发性硬化症患者急性呼吸道疾病的易感性。
Mult Scler Relat Disord. 2020 Aug;43:102195. doi: 10.1016/j.msard.2020.102195. Epub 2020 May 13.
8
Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum.接受免疫抑制剂治疗的多发性硬化症患者：在整个新冠疫情范围内。
Rev Neurol (Paris). 2020 Jun;176(6):523-525. doi: 10.1016/j.neurol.2020.04.009. Epub 2020 Apr 27.
9
The Coronavirus Disease 2019 (COVID-19) and Alcohol Use Disorders in Iran.伊朗的2019冠状病毒病（COVID-19）与酒精使用障碍
Am J Mens Health. 2020 Jul-Aug;14(4):1557988320938610. doi: 10.1177/1557988320938610.
10
Incidence of anxiety in epilepsy during coronavirus disease (COVID-19) pandemic.癫痫患者在冠状病毒病（COVID-19）大流行期间的焦虑发生率。
Epilepsy Behav. 2020 Nov;112:107442. doi: 10.1016/j.yebeh.2020.107442. Epub 2020 Sep 17.
引用本文的文献
1
Investigating COVID-19-Induced Adjustment Disorder Among Iranian Patients With Multiple Sclerosis in Pandemic Time.调查疫情期间伊朗多发性硬化症患者中的新冠肺炎诱发的适应障碍
Neuropsychopharmacol Rep. 2025 Jun;45(2):e70022. doi: 10.1002/npr2.70022.
2
Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic.在新冠疫情期间，多发性硬化症患者的社会支持、焦虑与心理弹性的相关性。
Curr J Neurol. 2023 Oct 7;22(4):217-220. doi: 10.18502/cjn.v22i4.14525.
3
Insomnia and common mental disorder among patients with pre-existing chronic non-communicable diseases in southern Ethiopia: a survey during COVID-19 pandemic.埃塞俄比亚南部患有慢性非传染性疾病患者的失眠和常见精神障碍：COVID-19大流行期间的一项调查。
Front Psychiatry. 2023 Sep 15;14:1142926. doi: 10.3389/fpsyt.2023.1142926. eCollection 2023.
4
The Psychological Impact of COVID-19 Pandemic on Persons with Multiple Sclerosis in Saudi Arabia.COVID-19 大流行对沙特阿拉伯多发性硬化症患者的心理影响。
Neurosciences (Riyadh). 2023 Apr;28(2):108-115. doi: 10.17712/nsj.2023.2.20110104.
5
Social isolation, loneliness and mental health sequelae of the Covid-19 pandemic in Parkinson's disease.新冠疫情对帕金森病患者的社会隔离、孤独感和心理健康后遗症的影响。
Int Rev Neurobiol. 2022;165:197-227. doi: 10.1016/bs.irn.2022.03.003. Epub 2022 Apr 23.
6
A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action.一项针对传染病（包括 COVID-19）中抑郁、焦虑和失眠的患病率及相关风险因素的系统回顾和荟萃分析：行动呼吁。
Mol Psychiatry. 2022 Aug;27(8):3214-3222. doi: 10.1038/s41380-022-01638-z. Epub 2022 Jun 6.
7
The Impact of COVID-19 on the Lives of Individuals With Multiple Sclerosis: 1 Year Into the Pandemic.新冠疫情对多发性硬化症患者生活的影响：疫情爆发一年之际
Int J MS Care. 2022 May-Jun;24(3):139-144. doi: 10.7224/1537-2073.2021-099. Epub 2022 May 24.
8
The influence of COVID-19 pandemic lockdown on the physical activity of people with multiple sclerosis. The role of online training.COVID-19 大流行封锁对多发性硬化症患者身体活动的影响。在线培训的作用。
Mult Scler Relat Disord. 2022 Jul;63:103843. doi: 10.1016/j.msard.2022.103843. Epub 2022 May 6.
9
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis.Covid-19 大流行对多发性硬化症患者的心理影响：一项荟萃分析。
Mult Scler Relat Disord. 2022 May;61:103774. doi: 10.1016/j.msard.2022.103774. Epub 2022 Mar 25.
10
Psychological impacts of COVID-19 pandemic on individuals living with multiple sclerosis: A rapid systematic review.2019冠状病毒病大流行对多发性硬化症患者的心理影响：一项快速系统评价
Mult Scler Relat Disord. 2022 Mar;59:103562. doi: 10.1016/j.msard.2022.103562. Epub 2022 Jan 25.
本文引用的文献
1
Clinical Utility of Beck Anxiety Inventory in Clinical and Nonclinical Korean Samples.贝克焦虑量表在韩国临床和非临床样本中的临床效用。
Front Psychiatry. 2018 Dec 4;9:666. doi: 10.3389/fpsyt.2018.00666. eCollection 2018.
2
Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review.压力作为多发性硬化症发病或复发的风险因素：系统评价。
Neuroepidemiology. 2011;36(2):109-20. doi: 10.1159/000323953. Epub 2011 Feb 17.
Zotero 插件